Live·Open questions in longevity research

In people with age-related immune dysfunction, what conditions are necessary and jointly sufficient to durably restore key functions of innate and adaptive immunity to levels within the ranges observed in healthy young adults, while preserving protective immunological memory, self-tolerance, and control of latent infections?

Can suppressing hidden infection versus neutralizing released damage material distinguish why tissue function worsens before recovery becomes impossible?

If hidden infection sustains injury, suppressing the responsible organism could interrupt the process that damages tissue. If material released by injured cells sustains further damage independently, suppressing infection alone could leave that process active.

The whole reason

However, released material can also support recovery: S3 reports that blocking one such signal removes inflammation-resolving effects, although its supplied quotation is unverified. Mistaking a protective signal for harmful material could therefore undermine recovery, while mistaking an intervention response for proof of the underlying cause could leave the actual driver unresolved. The supplied sources do not establish how long either mistake could persist before recovery becomes impossible.

The question in full

The question concerns worsening tissue function despite blood measurements suggesting that inflammation has returned to normal. It asks whether selectively suppressing disease-causing organisms, compared with neutralizing potentially harmful material released outside injured cells, can distinguish hidden infection from tissue damage that continues without infection. The comparison would need to show whether functional deterioration responds differently to the two interventions, and whether that difference identifies the responsible cause. The question assumes that existing monitoring detects this mismatch but cannot establish its cause, and asks whether the distinction can be made while recovery remains possible. Its broader setting is restoring immune function in people with age-related immune impairment.

What is in dispute

Each route below is a way this could work. They predict different things for the same measurement, which is what makes the question answerable at all.

  1. 01Clearing residual bacteria redirects protein-cutting enzymes toward host tissueIn some older adults with residual bacterial infection, clearing bacteria may remove proteins that compete with host tissue for enzyme cleavage. In paired tissue cultures, replacement with cleavable microbial protein must prevent injury without preserving infection; a cleavage-resistant counterpart must fail.
  2. 02Self-organized danger and inhibitor signals sustain tissue injury after infection clearsIn aged tissue, local extracellular danger signals and a more widely spreading inhibitor could sustain injury after microbial elimination. The claim depends on predicting injury spacing and abolishing persistent injury by redistributing inhibitor at matched mean exposure.
  3. 03Infection leaves chromosome damage that causes delayed tissue loss during repairIn donor-derived organoids, pre-existing chromosome damage causes delayed cell loss during repair despite pathogen suppression and extracellular cargo neutralization. Injury should follow faulty divisions and shift with a reversible delay in cell-cycle entry.
One route per published explanation of this question. Where none is published yet, the answers the question itself could have.

Suppose this is what we see

Pick a result the work could return and read what follows from it: the explanation it would support, what the others predict for the same measurement, and what to check next.

Suppose
In paired tissue cultures, pathogen suppression increases host-protein cleavage and new tissue injury after bacterial-substrate turnover, despite falling viable burden and unchanged protease abundance and intrinsic catalytic competence. Protease neutralization prevents this deterioration. Adding purified, readily cleavable microbial substrate during suppression also prevents injury without changing viable burden; a matched cleavage-resistant substrate does not. Isotope-resolved cleavage products must demonstrate reciprocal movement from microbial to host substrates. Failure of substrate replacement to rescue injury despite verified competition rejects this hypothesis. Non-lytic suppression, drug-only controls, and matched released microbial products distinguish substrate diversion from antibiotic toxicity or killing-induced toxin release. Supposition
It supports
Clearing residual bacteria redirects protein-cutting enzymes toward host tissueIn some older adults with residual bacterial infection, clearing bacteria may remove proteins that compete with host tissue for enzyme cleavage. In paired tissue cultures, replacement with cleavable microbial protein must prevent injury without preserving infection; a cleavage-resistant counterpart must fail.
The others predict
  • Self-organized danger and inhibitor signals sustain tissue injury after infection clearsAfter independently verified pathogen elimination, spatial imaging reveals a reproducible injury wavelength that emerges from small perturbations. A model fitted before intervention must predict how changing inhibitor spread changes that wavelength. Spatial redistribution of inhibitor at matched mean exposure can abolish persistent injury, whereas the same mean exposure delivered in the original pattern does not. Uniform, well-mixed preparations relax toward recovery under matched reaction conditions. Cargo neutralization sufficient to remove the instability prevents pattern reformation; pathogen suppression alone does not. Absence of measurable local self-amplification, longer-range inhibition, or a diffusion-induced unstable mode rejects this specific mechanism rather than being excused as generic feedback.
  • Infection leaves chromosome damage that causes delayed tissue loss during repairWith verified pathogen suppression and sustained extracellular cargo neutralization, new injury still follows aberrant divisions of cells carrying pre-existing chromosome lesions. Live lineage imaging shows chromosome bridges, segregation errors, or micronucleus formation before cell loss. A reversible experimental delay of cell-cycle entry shifts injury onset by the corresponding interval; releasing the delay restores division-associated injury unless lesions have resolved. Conditioned medium collected before those divisions does not transfer the phenotype to undamaged cells. Pathogen-directed treatment, cargo neutralization, and their combination fail to prevent the initial delayed deaths, distinguishing this mechanism from both extracellular rivals.
What to check next
When blood inflammation measurements normalize but tissue function worsens, can suppressing infection versus neutralizing released damage material identify the cause?

Choosing an answer changes this view only. No assessment moves and no explanation gains standing from it.

The explanations that compete for it

Each one was written for this question alone, and each names the observation that would settle it against the others.

01

Clearing residual bacteria redirects protein-cutting enzymes toward host tissue

Catalytic substrate competition
What it says happens

In some older adults with residual bacterial infection, clearing bacteria may remove proteins that compete with host tissue for enzyme cleavage.

Full text

In a subset of older adults with residual bacterial infection, renewed microbial protein production competitively diverts extracellular neutrophil proteases away from host proteins. Pathogen suppression stops this substrate supply; after existing bacterial substrates disappear, unchanged protease molecules redirect cleavage toward host tissue. Functional deterioration therefore reflects a clearance-triggered redistribution of catalytic activity, rather than greater pathogen abundance or increasing injury-cargo concentration. Replacing the competing substrate with a noninfectious equivalent during clearance should stabilize SPV_5 without preserving infection.

The prediction that separates it

In paired tissue cultures, pathogen suppression increases host-protein cleavage and new tissue injury after bacterial-substrate turnover, despite falling viable burden and unchanged protease abundance and intrinsic catalytic competence.

Full text

Protease neutralization prevents this deterioration. Adding purified, readily cleavable microbial substrate during suppression also prevents injury without changing viable burden; a matched cleavage-resistant substrate does not. Isotope-resolved cleavage products must demonstrate reciprocal movement from microbial to host substrates. Failure of substrate replacement to rescue injury despite verified competition rejects this hypothesis. Non-lytic suppression, drug-only controls, and matched released microbial products distinguish substrate diversion from antibiotic toxicity or killing-induced toxin release.

What would weaken it

Self-organized danger and inhibitor signals sustain tissue injury after infection clears predicts instead: After independently verified pathogen elimination, spatial imaging reveals a reproducible injury wavelength that emerges from small perturbations.

Full text

A model fitted before intervention must predict how changing inhibitor spread changes that wavelength. Spatial redistribution of inhibitor at matched mean exposure can abolish persistent injury, whereas the same mean exposure delivered in the original pattern does not. Uniform, well-mixed preparations relax toward recovery under matched reaction conditions. Cargo neutralization sufficient to remove the instability prevents pattern reformation; pathogen suppression alone does not. Absence of measurable local self-amplification, longer-range inhibition, or a diffusion-induced unstable mode rejects this specific mechanism rather than being excused as generic feedback.

Infection leaves chromosome damage that causes delayed tissue loss during repair predicts instead: With verified pathogen suppression and sustained extracellular cargo neutralization, new injury still follows aberrant divisions of cells carrying pre-existing chromosome lesions. Live lineage imaging shows chromosome bridges, segregation errors, or micronucleus formation before cell loss. A reversible experimental delay of cell-cycle entry shifts injury onset by the corresponding interval; releasing the delay restores division-associated injury unless lesions have resolved. Conditioned medium collected before those divisions does not transfer the phenotype to undamaged cells. Pathogen-directed treatment, cargo neutralization, and their combination fail to prevent the initial delayed deaths, distinguishing this mechanism from both extracellular rivals.

02

Self-organized danger and inhibitor signals sustain tissue injury after infection clears

Information and sensing
What it says happens

In aged tissue, local extracellular danger signals and a more widely spreading inhibitor could sustain injury after microbial elimination.

Full text

Post-clearance injury persists because short-range extracellular danger signaling and longer-range inhibitory signaling generate a self-organized spatial pattern. Histone-associated injury induces additional local cargo release, while stimulated tissue cells produce a more widely spreading inhibitor such as SLPI. An aged tissue can consequently maintain sharply localized injury domains surrounded by relatively quiet tissue even after microbial elimination. The causal state resides in a distributed activator–inhibitor field, not in a mechanically altered matrix or a permanently switched cell population. Extinguishing the spatial instability should stabilize SPV_5.

The prediction that separates it

After independently verified pathogen elimination, spatial imaging reveals a reproducible injury wavelength that emerges from small perturbations.

Full text

A model fitted before intervention must predict how changing inhibitor spread changes that wavelength. Spatial redistribution of inhibitor at matched mean exposure can abolish persistent injury, whereas the same mean exposure delivered in the original pattern does not. Uniform, well-mixed preparations relax toward recovery under matched reaction conditions. Cargo neutralization sufficient to remove the instability prevents pattern reformation; pathogen suppression alone does not. Absence of measurable local self-amplification, longer-range inhibition, or a diffusion-induced unstable mode rejects this specific mechanism rather than being excused as generic feedback.

What would weaken it

Clearing residual bacteria redirects protein-cutting enzymes toward host tissue predicts instead: In paired tissue cultures, pathogen suppression increases host-protein cleavage and new tissue injury after bacterial-substrate turnover, despite falling viable burden and unchanged protease abundance and intrinsic catalytic competence.

Full text

Protease neutralization prevents this deterioration. Adding purified, readily cleavable microbial substrate during suppression also prevents injury without changing viable burden; a matched cleavage-resistant substrate does not. Isotope-resolved cleavage products must demonstrate reciprocal movement from microbial to host substrates. Failure of substrate replacement to rescue injury despite verified competition rejects this hypothesis. Non-lytic suppression, drug-only controls, and matched released microbial products distinguish substrate diversion from antibiotic toxicity or killing-induced toxin release.

Infection leaves chromosome damage that causes delayed tissue loss during repair predicts instead: With verified pathogen suppression and sustained extracellular cargo neutralization, new injury still follows aberrant divisions of cells carrying pre-existing chromosome lesions. Live lineage imaging shows chromosome bridges, segregation errors, or micronucleus formation before cell loss. A reversible experimental delay of cell-cycle entry shifts injury onset by the corresponding interval; releasing the delay restores division-associated injury unless lesions have resolved. Conditioned medium collected before those divisions does not transfer the phenotype to undamaged cells. Pathogen-directed treatment, cargo neutralization, and their combination fail to prevent the initial delayed deaths, distinguishing this mechanism from both extracellular rivals.

03

Infection leaves chromosome damage that causes delayed tissue loss during repair

Replication coupled genomic failure
What it says happens

In donor-derived organoids, pre-existing chromosome damage causes delayed cell loss during repair despite pathogen suppression and extracellular cargo neutralization.

Full text

The initiating infection leaves chromosome damage in surviving epithelial progenitors. Blood inflammation then normalizes and pathogens are controlled, but regeneration forces damaged cells through replication and mitosis, producing delayed chromosome segregation failure and tissue-cell loss. Neither persistent viable organisms nor ongoing extracellular histone/protease activity is necessary once these lesions exist. The maladaptive substrate is unrepaired nuclear chromosome damage whose consequences become expressed during attempted regeneration. Preventing catastrophic regeneration while preserving productive repair should stabilize SPV_5.

The prediction that separates it

With verified pathogen suppression and sustained extracellular cargo neutralization, new injury still follows aberrant divisions of cells carrying pre-existing chromosome lesions.

Full text

Live lineage imaging shows chromosome bridges, segregation errors, or micronucleus formation before cell loss. A reversible experimental delay of cell-cycle entry shifts injury onset by the corresponding interval; releasing the delay restores division-associated injury unless lesions have resolved. Conditioned medium collected before those divisions does not transfer the phenotype to undamaged cells. Pathogen-directed treatment, cargo neutralization, and their combination fail to prevent the initial delayed deaths, distinguishing this mechanism from both extracellular rivals.

What would weaken it

Clearing residual bacteria redirects protein-cutting enzymes toward host tissue predicts instead: In paired tissue cultures, pathogen suppression increases host-protein cleavage and new tissue injury after bacterial-substrate turnover, despite falling viable burden and unchanged protease abundance and intrinsic catalytic competence.

Full text

Protease neutralization prevents this deterioration. Adding purified, readily cleavable microbial substrate during suppression also prevents injury without changing viable burden; a matched cleavage-resistant substrate does not. Isotope-resolved cleavage products must demonstrate reciprocal movement from microbial to host substrates. Failure of substrate replacement to rescue injury despite verified competition rejects this hypothesis. Non-lytic suppression, drug-only controls, and matched released microbial products distinguish substrate diversion from antibiotic toxicity or killing-induced toxin release.

Self-organized danger and inhibitor signals sustain tissue injury after infection clears predicts instead: After independently verified pathogen elimination, spatial imaging reveals a reproducible injury wavelength that emerges from small perturbations. A model fitted before intervention must predict how changing inhibitor spread changes that wavelength. Spatial redistribution of inhibitor at matched mean exposure can abolish persistent injury, whereas the same mean exposure delivered in the original pattern does not. Uniform, well-mixed preparations relax toward recovery under matched reaction conditions. Cargo neutralization sufficient to remove the instability prevents pattern reformation; pathogen suppression alone does not. Absence of measurable local self-amplification, longer-range inhibition, or a diffusion-induced unstable mode rejects this specific mechanism rather than being excused as generic feedback.

No test is published for this question yet

What stands in its place is above: each explanation states the measurement that would separate it from the others.

What to check next: When blood inflammation measurements normalize but tissue function worsens, can suppressing infection versus neutralizing released damage material identify the cause?

Every proposed test →

What the literature settles, and what it does not

The sources read against this question, the assumption it rests on, and the verdict that follows.

Can suppressing hidden infection versus neutralizing released damage material distinguish why tissue function worsens before recovery becomes impossible?

What this question is asking

The question concerns worsening tissue function despite blood measurements suggesting that inflammation has returned to normal. It asks whether selectively suppressing disease-causing organisms, compared with neutralizing potentially harmful material released outside injured cells, can distinguish hidden infection from tissue damage that continues without infection. The comparison would need to show whether functional deterioration responds differently to the two interventions, and whether that difference identifies the responsible cause. The question assumes that existing monitoring detects this mismatch but cannot establish its cause, and asks whether the distinction can be made while recovery remains possible. Its broader setting is restoring immune function in people with age-related immune impairment.

What the terms mean
Inflammation and blood inflammation measurements
Inflammation is a biological response associated with infection, injury, and repair. Blood measurements track selected features of that response; the supplied input does not identify the measurements or define what counts as normal.
Tissue function and recovery limits
Tissue function means how well a body tissue performs its role. Recovery limits name the proposed boundary beyond which that performance cannot be restored; no such boundary is specified or validated here.
Occult infection and selective pathogen suppression
Occult infection means infection that has not been readily detected. Selective pathogen suppression means reducing the disease-causing organism with an intervention intended to act specifically on it.
Extracellular injury cargo and neutralization
This means material released outside cells during injury, and interventions intended to prevent its harmful activity. It is a broad class of material, not one substance, and released material can also participate in recovery.
Autonomous tissue damage
Here this means injury that continues without requiring an ongoing infection. The supplied sources do not establish that independence in the situation posed.
Age-related immune impairment
This means reduced or altered performance of the body's defenses associated with aging. The question's broader aim concerns restoring those defenses, but the supplied studies do not establish that outcome.
RL-2 discordance rules and RL-3 functional tests
These are pipeline labels for rules that flag mismatched measurements and tests of biological performance. Their expansions, procedures, and validation are not provided.
Tissue antigen and injury signatures
An antigen is biological material recognizable by the immune system; an injury signature is a pattern of measurements associated with damage. Finding either does not automatically explain whether the detected material or process is sustaining the damage.
Connexin-43 channels and Peptide5
Connexin-43 forms channels in cell membranes. Peptide5 is the channel-blocking intervention associated with protection in the mouse study described by S1.
Interleukin-1 beta
An immune signaling protein blocked in S2. That study's reported healing outcome cautions against assuming that blocking an inflammation-related signal necessarily improves repair.
Extracellular vesicles
Small membrane-enclosed packages released by cells that carry biological material. They are a class of packages with different contents and effects, including the protective effects described in S3 and injury-associated material examined in S4.
Prosaposin and receptor
Prosaposin is the molecule implicated in the protective signaling described in S3. A receptor is a protein that receives a biological signal; the supplied title and quotation spell this study's receptor label differently.
Nucleic acids and Toll-like receptors 3 and 9
Nucleic acids are molecules that carry genetic information and can also stimulate immune responses when released from cells. Toll-like receptors 3 and 9 are immune sensors whose activation S4 reports inhibiting through nucleic-acid capture.
Fluorodeoxyglucose positron emission tomography
An imaging method using a detectable sugar-like tracer to locate areas of biological activity. S5 discusses its limited ability to distinguish infection from cancer and inflammation without infection.
What the question takes for granted
Premise only partly supported
RL-2 discordance rules and RL-3 functional tests detect abnormalities; tissue antigen and injury signatures do not establish the responsible driver.

The pipeline describes monitoring rules and tests of biological performance that flag a mismatch between reassuring blood results and worsening function. It also assumes that finding recognizable biological material or signs of injury in tissue does not identify what keeps the damage going. If this holds, detecting an abnormality and identifying its cause are separate problems, which motivates the proposed comparison.

S5 supports a narrower concern: the imaging method it discusses sometimes poorly distinguishes infection, cancer, and inflammation without infection. It does not establish the performance of the pipeline's monitoring rules, functional tests, or tissue measurements. The supplied sources do not establish that these rules detect deterioration during a defined period when recovery remains possible.S5

The same question asked without the part nothing read establishes:

  • When blood inflammation measurements normalize but tissue function worsens, can suppressing infection versus neutralizing released damage material identify the cause?
  • Can responses to infection suppression and released-material neutralization distinguish infection-driven injury from injury that continues independently of infection?
What turns on the answer
  • The responses distinguish the causes Under the question's proposed logic, improvement specifically following infection suppression would support infection as a continuing driver, while improvement specifically following neutralization would support released material as a driver. For this to identify the cause, the responses would need to distinguish those explanations reliably; the supplied sources do not establish that reliability or whether the distinction arrives before recovery is lost.
  • The responses do not distinguish the causes If both interventions help, neither helps, or their effects cannot be attributed specifically to their intended targets, the response pattern would leave the cause unresolved. Improvement alone would then be insufficient to classify the deterioration as hidden infection or independently continuing tissue damage.
  • The distinction arrives too late Even a reliable distinction could fail the timing requirement if it becomes apparent only after function can no longer recover. Identifying the cause would then settle the explanatory question without establishing the early warning capability the pipeline requires.
Why it matters

If hidden infection sustains injury, suppressing the responsible organism could interrupt the process that damages tissue. If material released by injured cells sustains further damage independently, suppressing infection alone could leave that process active. However, released material can also support recovery: S3 reports that blocking one such signal removes inflammation-resolving effects, although its supplied quotation is unverified. Mistaking a protective signal for harmful material could therefore undermine recovery, while mistaking an intervention response for proof of the underlying cause could leave the actual driver unresolved. The supplied sources do not establish how long either mistake could persist before recovery becomes impossible.

Still open

The question remains open within the supplied sources. S1 and S4 report effects of interventions on injury-related processes; S2 and S3 show that blocking particular signals can also compromise healing or inflammation resolution; S5 describes limitations of distinguishing causes by imaging. None tests the proposed diagnostic comparison or its timing against loss of recoverable function. The inference from these sources is that changing an injury-related process does not, by itself, establish what initiated or sustains it. This bounded set does not establish that the question is unanswered throughout the literature.S1S4S2S3S5

What the literature establishes
  • S1 reports that Peptide5, a blocker of cell-membrane channels formed by connexin-43, conferred protection in mice with experimental obstruction of urine flow from one kidney. The supplied quotation does not specify the protected outcome or the size of the benefit.S1
  • S2 reports apparently impaired bone healing after blocking interleukin-1 beta in a mouse injury study, while qualifying the effect as not marked. The supplied wording does not establish a clear effect size or statistical conclusion.S2
  • S3's abstract reports that interfering with prosaposin or its associated receptor eliminated the inflammation-resolving effects of extracellular vesicles released by cells that clear dying cells. This source was available only as an abstract, and the supplied quotation is marked unverified.S3
  • S4's abstract reports that a material designed to capture nucleic acids neutralized both freely released and vesicle-associated nucleic acids and inhibited activation of the immune sensors Toll-like receptors 3 and 9. The reported systems concern ultraviolet-damaged human skin cells and a mouse skin-inflammation model.S4
  • S5 reports that fluorodeoxyglucose positron emission tomography sometimes poorly differentiates infection, cancer, and inflammation occurring without infection.S5
What it does not settle
  • None of the supplied sources compares selective pathogen suppression with neutralization of released injury material as a way to identify the cause of deteriorating tissue function.
  • The supplied sources do not establish this distinction in people whose blood inflammation measurements have normalized while function continues to worsen, including people with age-related immune impairment.
  • It remains unsettled whether an intervention response would distinguish the original cause from a process shared by infection and tissue injury, or establish that damage continues independently of infection.
  • No supplied source establishes a recovery limit, a clinically justified deterioration threshold, or how much earlier the proposed comparison would identify the cause than subsequent functional decline.
Where the sources disagree
  • The intervention findings caution against treating all released material or inflammation-related signaling as harmful. S4 reports neutralization of released nucleic acids with reduced immune-sensor activation, whereas S3 reports loss of inflammation-resolving effects when a vesicle-associated signaling pathway is blocked, and S2 describes apparently impaired bone healing after signal blockade. These are different targets and settings, so they conflict with a blanket expectation of benefit from neutralization rather than directly contradicting one another.S2S3S4
Sources read · 5

4 literature searches, 2 full texts, 3 abstract-only; 5 source(s) read in full against this question. A bounded search is not evidence of absence.

S1Partly answers it

Connexin-43 hemichannels orchestrate NOD-like receptor protein-3 (NLRP3) inflammasome activation and sterile inflammation in tubular injury. · Cell communication and signaling : CCS · 2023

Cx43 specific hemichannel blocker Peptide5 conferred similar protection in UUO mice.

Does not settle: It does not test pathogen suppression, occult infection, normalized blood inflammation with deteriorating function, or whether contrasting interventions can distinguish infection from autonomous tissue damage before recovery limits.

S2Partly answers it

NLRP3-Dependent Crosstalk between Pyroptotic Macrophage and Senescent Cell Orchestrates Trauma-Induced Heterotopic Ossification During Aberrant Wound Healing. · Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023

The results showed that Micro‐CT analysis at 10 weeks appeared damaged osteogenic healing after IL‐1 β blocking, though the effects were not markedly (Figure ).

Does not settle: This murine trauma-induced heterotopic-ossification study examines IL-1β blockade and extracellular-vesicle secretion inhibition, not selective pathogen suppression versus injury-cargo neutralization as a diagnostic comparison. It does not establish occult infection, normalized blood inflammation with deteriorating function, or recovery-limit timing.

S3BackgroundAbstract onlyQuote unverified

Efferocytes release extracellular vesicles to resolve inflammation and tissue injury via prosaposin-GPR37 signaling. · Cell reports · 2023

Neutralization and knockdown of prosaposin or blocking GRP37 abrogates the pro-resolution effects of efferocyte-derived EVs in vivo.

Does not settle: It does not test selective pathogen suppression, occult infection, extracellular injury-cargo neutralization as a diagnostic comparison, functional deterioration despite normalized blood inflammation, recovery limits, or human tissue outcomes.

S4Partly answers itAbstract only

Cationic nanotrap curbs UVB-induced cutaneous photodamage via exosomal cfNA capture. · Biomaterials · 2026

WSP inhibited TLR3 and 9 activation induced by nucleic-acid agonists, UVB-conditioned media from HDFs and NHEKs, and exosomes derived from UVB-damaged HDFs, indicating effective neutralization of both soluble and vesicle-associated cfNAs.

Does not settle: It does not test selective pathogen suppression, compare the two interventions as a diagnostic distinction, assess blood inflammation with functional deterioration, or establish recovery limits. The reported system is UVB-damaged human skin cells and a murine UVB skin-inflammation model.

S5BackgroundAbstract only

What, where and why: exploring fluorodeoxyglucose-PET's ability to localise and differentiate infection from cancer. · Current opinion in infectious diseases · 2017

Limitations include at times poor differentiation between infection, malignancy and sterile inflammation, however, exciting new technologies specific to infectious pathogens may help alleviate that issue.

Does not settle: It does not assess selective pathogen suppression or extracellular injury-cargo neutralization, functional deterioration with normalized blood inflammation, autonomous tissue damage, recovery limits, or whether either intervention can distinguish occult infection from tissue damage.

← Every open question